Efficacy of topical nerve growth factor treatment in dogs affected by dry eye

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 2, 2005, Pages 151-155

  Coassin, Marco ^a   Lambiase, Alessandro ^a,b   Costa, Nicola ^c   De Gregorio, Alessandra ^d   Sgrulletta, Roberto ^a,b   Sacchetti, Marta ^a   Aloe, Luigi ^e   Bonini, Stefano ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d FATEBENEFRATELLI HOSPITAL   (Italy)

^e CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

ARTICLE; CELL DENSITY; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DOG; DRUG EFFICACY; DRY EYE; FEMALE; FOLLOW UP; GOBLET CELL; IMPRESSION CYTOLOGY; KERATOCONJUNCTIVITIS SICCA; LACRIMAL GLAND DISEASE; MALE; NONHUMAN; OPEN STUDY; PRIORITY JOURNAL; RISK REDUCTION; SCHIRMER TEST; SCORING SYSTEM; TEAR FLOW; VISUAL SYSTEM EXAMINATION;

ADMINISTRATION, TOPICAL; ANIMALS; CONJUNCTIVA; CORNEA; DOG DISEASES; DOGS; DRY EYE SYNDROMES; FEMALE; GOBLET CELLS; KERATOCONJUNCTIVITIS SICCA; MALE; MUCINS; NERVE GROWTH FACTOR; TEARS;

EID: 14944366026     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-0955-2     Document Type: Article

References (40)

1. Baudouin C (2001) The pathology of dry eye. Surv Ophthalmol 45:S211-S220 10.1016/S0039-6257(00)00200-9
2. Benitez-del-Castillo JM, del Rio T et al (2001) Decrease in tear secretion and corneal sensitivity after laser in situ keratomileusis. Cornea 20:30-32 10.1097/00003226-200101000-00005
3. Bocchini V, Angeletti PU (1969) The nerve growth factor: Purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci U S A 64:787-794
4. Bonini S, Lambiase A, Rama P et al (2000) Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107:1347-1351
5. Bounous DI, Krenzer KL, Kaswan RL et al (1998) Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine. Adv Exp Med Biol 438:997-1000
6. Brooks DE (1991) Canine conjunctiva and nictitating membrane. In: Gelatt KN (ed) Veterinary ophthalmology, 2nd edn. Lea & Febiger, Philadelphia, pp 290-306
7. Calonge M (2001) The treatment of dry eye. Surv Ophthalmol 45:S227-S239 10.1016/S0039-6257(00)00205-8
8. Fantes FE, Hanna KD, Waring GO et al (1990) Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol 108:665-675
9. Faulkner WJ, Varley GA (1997) Corneal diagnostic technique. In: Krachmer JH, Mannis MJ, Holland EJ (eds) Cornea: Fundamentals of cornea and external disease. Mosby, St Louis, pp 275-281
10. Fujishima H, Shimazaki J, Yagi Y et al (1996) Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: A preliminary study 15:368-375
11. Gelatt KN (1991) Canine lacrimal and nasolacrimal diseases. In: Gelatt KN (ed) Veterinary ophthalmology, 2nd edn. Lea & Febiger, Philadelphia, 276-289
12. Gelatt KN, Peiffer RL Jr, Erickson JL, Gum GG (1975) Evaluation of tear formation in the dog, using a modification of the Schirmer tear test. J Am Vet Med Assoc 166:368-370
13. Green LA (1977) A quantitative bioassay for nerve growth factor (NGF) activity employing a clonal pheochromocytoma cell line. Brain Res 133:350-353 10.1016/0006-8993(77)90770-3
14. Heigle TJ, Pflugfelder SC (1996) Aqueous tear production in patients with neurotrophic keratitis. Cornea 15:135-138
15. Helper LC (1996) The tear film in the dog. Cause and treatment of diseases associated with overproduction and underproduction of tears. Anim Eye Res 15:5-11
16. Helper LC, Magrane WG, Koehm J (1974) Surgical induction of keratoconjunctivitis sicca in the dog. J Am Vet Med Assoc 165:172-174
17. Kruse FE, Tseng SCG (1993) Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci 34:1963-1976
18. Kuchle M, Cursiefen C, Nguyen NX et al (2002) Risk factors for corneal allograft rejection: Intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol 240:580-584
19. Lambiase A, Bonini S, Micera A et al (1998) Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 39:1272-1275
20. Lambiase A, Rama P, Bonini S et al (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 338:1174-1180 10.1056/NEJM199804233381702
21. Lambiase A, Manni L, Bonini S et al (2000) Nerve growth factor promotes corneal healing: Structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci 41:1063-1069
22. Lambiase A, Bonini S, Aloe L et al (2000) Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol 118:1446-1449
23. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 4819:1154-1162
24. Micera A, Vigneti E, Pickholtz D et al (2001) Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A 98:6162-6167 10.1073/pnas.101130898
25. Moore CP, McHugh JB, Thorne JG, Phillips TE (2001) Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model. Invest Ophthalmol Vis Sci. 42:653-659
26. Nava A, Barton K, Monroy DC et al (1997) The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea 16:430-438
27. Nishida T. Cornea (1997) In: Krachmer JK, Mannis MJ, Holland EJ (eds) Cornea: Fundamentals of cornea and external disease, vol. 1. Mosby, St Louis, pp 3-27
28. Pflugfelder SC, Solomon A, Stern ME (2000) The diagnosis and management of dry eye: A twenty-five-year review. Cornea 19:644-649 10.1097/ 00003226-200009000-00009
29. Rios JD, Zoukhri D, Rawe IM et al (1999) Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion. Invest Ophthalmol Vis Sci 40:1102-1111
30. Rolando M, Baldi F, Calabria GA (1986) Tear mucus ferning test in keratoconjunctivitis sicca. In: Holly F (ed) The precorneal tear film in health, diseases, and contact lens wear. Dry Eye Institute, Lubbock, 203-210
31. Rolando M, Zierhut M (2001) The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 45:S203-S210 10.1016/ S0039-6257(00)00203-4
32. Rubin LF, Lynch RK, Stockman WS (1965) Clinical estimation of lacrimal function in dogs. J Am Vet Med Assoc 147:946-947
33. Schultz GS, Davis JB, Eiferman RA (1988) Growth factors and corneal epithelium. Cornea 7:96-101
34. Smith RE, Sadun AA (1998) Clearing the cornea with nerve growth factor. N Engl J Med 338:1222-1223 10.1056/NEJM199804233381710
35. Stanisz A, Scicchitano R, Stead R et al (1987) Neuropeptides and immunity. Am Rev Respir Dis 136:S48-S51
36. Stern ME, Beuerman RW, Fox RI et al (1998) The pathology of dry eye: The interaction between the ocular surface and lacrimal glands. Cornea 17:584-589 9820935
37. Versura P, Cellini M, Torreggiani A et al (2001) Dryness symptoms, diagnostic protocol and therapeutic management: A report on 1,200 patients. Ophthalmic Res 33:221-227 10.1159/000055674
38. Wilson SE, Kim WJ (1998) Keratocyte apoptosis: Implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci 39:220-226
39. Yanai R, Yamada N, Kugimiya N et al (2002) Mitogenic and antiapoptotic effects of various growth factors on human corneal fibroblasts. Invest Ophthalmol Vis Sci 43:2122-2126
40. You L, Kruse FE, Volcker HE (2000) Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci 41:692-702